nLIGHT, Inc. (NASDAQ: LASR) — 2019 Form 10-K
Business context and reporting period. The filing covers the fiscal year ended December 31, 2019; Q4 figures are also reported. nLIGHT designs and manufactures high-power semiconductor and fiber lasers for industrial, microfabrication, and aerospace and defense markets. In November 2019, it acquired Nutronics, a developer of laser and beam-control systems for defense applications, for approximately $17.4 million. The acquisition added an Advanced Development segment; results include Nutronics from November 14, 2019.
Financial performance and position
| Metric | 2019 | 2018 |
|---|---|---|
| Revenue | $176.6 million | $191.4 million |
| Gross profit / gross margin | $52.3 million / 29.6% | $67.0 million / 35.0% |
| Operating income (loss) | $(9.9) million | $17.1 million |
| Net income (loss) | $(12.9) million | $13.9 million |
| Diluted EPS | $(0.35) | $0.32 |
| Cash from (used in) operations | $(4.2) million | $3.3 million |
| Cash and cash equivalents at year-end | $117.3 million | $149.5 million |
| Working capital | $173.6 million | $195.0 million |
| Total debt, including current portion | $0.05 million | $0.11 million |
2019 investing cash outflow was $30.4 million, including $17.4 million for Nutronics and $13.6 million in capital expenditures. Financing cash inflow was $2.5 million. The company had a $40 million revolving credit facility with no borrowings outstanding and full availability at year-end; it reported compliance with its covenants. Management said existing liquidity should cover working capital and capital expenditure needs for at least 12 months.
Q4 2019 revenue was $42.9 million versus $46.2 million in Q4 2018; gross profit was $10.0 million versus $16.5 million. Q4 net loss was $10.7 million, compared with net income attributable to common stockholders of $2.4 million a year earlier.
Material changes versus prior period
- Full-year revenue fell 7.7%. Industrial revenue declined 7.4% to $76.7 million, and Microfabrication revenue fell 22.9% to $57.2 million. Aerospace and Defense revenue rose 24.1% to $42.8 million.
- Revenue by geography declined across North America, China, and the rest of the world; China contributed $64.1 million, or 36.3% of revenue.
- Gross margin declined 5.4 percentage points to 29.6%, attributed to lower pricing in some Industrial products, lower production volume and factory utilization, and higher tariffs, partly offset by product cost improvements.
- Research and development expense rose 33.6% to $28.1 million; sales, general and administrative expense rose 18.3% to $34.1 million. Higher compensation and stock-based compensation, R&D investment, acquisition costs, and public-company expenses contributed.
- Stock-based compensation increased to $9.7 million from $4.8 million. The 2019 tax expense included a $3.4 million valuation allowance charge on China deferred tax assets, as described in management’s discussion.
- Backlog rose to $112.1 million from $38.0 million; approximately 25% of year-end 2019 backlog was not expected to be filled within 12 months. Backlog may be canceled or deferred and is not a guarantee of revenue.
Outlook, risks, contingencies, and unusual items
- Management anticipated continued near-term average selling price pressure, particularly in China’s Industrial market, which could reduce revenue or slow growth. Further margin effects from tariffs were also possible if costs could not be passed through.
- The filing warned that COVID-19 was expected to adversely affect Q1 2020 revenue and potentially later periods, citing temporary Shanghai office and customer and supplier facility closures, travel restrictions, and supply-chain disruption. No quantified full-year forecast was provided.
- Key exposures include dependence on China and international operations, customer and end-market concentration, cyclical Industrial and Microfabrication demand, competitive pricing, fixed manufacturing costs, inventory obsolescence, limited-source suppliers, foreign exchange, and government defense budgets and export controls. The top ten customers generated about 53% of 2019 revenue; Raytheon accounted for 13% and Quick Laser Technology for 11%.
- The company reported an ongoing U.S. Attorney’s Office Criminal Division inquiry related to historical eligibility for Small Business Innovation Research contracts. A separate 2015 civil settlement of $420,000 was paid in full; the filing says the criminal inquiry’s outcome and timing are uncertain.
- Nutronics contributed $2.6 million in revenue and $0.3 million in gross profit in its post-acquisition stub period. The purchase-price allocation was preliminary; integration and realization of expected synergies remain risks.
- In November 2019, the board authorized up to $10 million in share repurchases, intended to offset potential dilution from Nutronics-related restricted stock grants. No shares had been repurchased by year-end.
- The audit opinion was unqualified. Management concluded internal control over financial reporting was effective, but excluded Nutronics’ controls from its assessment because integration was incomplete. The auditor was not required to audit internal control effectiveness.
Investor verification priorities
- Track whether the $112.1 million backlog converts to revenue, especially the portion expected beyond 12 months, and monitor cancellations or delivery delays.
- Verify recovery in Industrial and Microfabrication demand and assess pricing, factory utilization, tariff costs, and gross-margin direction.
- Monitor COVID-19 effects on China operations, suppliers, customers, and reported 2020 results against the filing’s Q1 warning.
- Assess operating cash generation, inventory growth (up to $46.1 million from $35.3 million), and planned capital spending against the company’s liquidity outlook.
- Review Nutronics integration, final purchase accounting, acquisition-related stock compensation, and performance of the Advanced Development segment.
- Follow the unresolved criminal inquiry, tax valuation allowances and uncertain tax positions, and the $40 million credit facility’s covenants and availability.